drugset / Trial / NCT00712283
Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers
RandomizedParallel-groupTriple-blind
Summary
Determination of the ability to drive and operate machines after single and multiple oral dose of Neramexane as compared to placebo
Timeline
- Start
- 2008-07
- Primary completion
- 2009-03
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neramexane | Small molecule | 25 mg | Oral |
| Comparator | Neramexane | Small molecule | 50 mg | Oral |
| Comparator | Neramexane | Small molecule | 75 mg | Oral |
Indications
No indication recorded.